|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating expenses: | |||
| Research and development | |||
| General and administrative | |||
| Other license income | |||
| Gains on sale of non-financial assets | |||
| Total operating expenses | |||
| Loss from operations | |||
| Interest and other income, net | |||
| Loss before provision for income taxes | |||
| Provision for income taxes | |||
| Net loss attributable to ordinary shareholders | |||
| Net loss per share, basic | |||
| Net loss per share, diluted | |||
| Weighted-average ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic | |||
| Weighted-average ordinary shares used in computing net loss per share attributable to ordinary shareholders, diluted | |||
| Other comprehensive income: | |||
| Unrealized gain on investments, net | |||
| Total other comprehensive income | |||
| Comprehensive loss |
Loading...
